Four amino acids, four different jobs
Tyrosine, glycine, taurine, and L-theanine are neurologically active nutrients used for different goals: tyrosine for demand-linked focus, glycine for sleep onset, taurine for neural regulation, and L-theanine for calm attention. They are not interchangeable, and the doses used in isolated-ingredient studies should not be treated as universal dosing recommendations.
| Ingredient | Primary role | Common human study dose | Most defensible goal | What it does not establish |
|---|---|---|---|---|
| Tyrosine | Precursor to dopamine and norepinephrine | Often 2,000 mg acutely; some trials use weight-based doses | Preserving focus during short-term stress or heavy cognitive demand | Universal motivation, energy, or ADHD treatment |
| Glycine | Inhibitory signaling and NMDA-receptor co-activation | 3,000 mg before bed in small sleep studies | Sleep onset, sleep quality, and next-day recovery | A guaranteed sedative effect or treatment for chronic insomnia |
| Taurine | Neuromodulation, cellular signaling, and calcium regulation | Typically 1,000–3,000 mg in acute cognitive studies | A supporting role in calm-focus or neural-health formulas | Reliable memory or cognitive enhancement |
| L-theanine | Relaxed attention and stress-response support | Commonly 200 mg as an acute dose | Calm without making sedation the primary objective | Consistent treatment of anxiety or a pharmaceutical sleep effect |
Representative doses come from human research on 2,000 mg tyrosine, 3,000 mg glycine before bed, 1,000–3,000 mg taurine, and 200 mg L-theanine.
Tyrosine: focus when stress is consuming mental bandwidth
Tyrosine is an amino acid the body uses to make catecholamines, including dopamine and norepinephrine. That mechanism makes it most relevant when stress, cold, sleep loss, or sustained cognitive demand is temporarily straining the systems involved in attention and working memory.
Typical studied dose: Acute cognitive studies commonly use about 2,000 mg, while some research has used substantially higher weight-based doses. A research review found the clearest benefits under short-term stressful or cognitively demanding conditions rather than during ordinary, unstressed performance. PubMed’s tyrosine evidence review summarizes this demand-dependent pattern.
What it supports: Focus, working memory, and mental performance when stress is the reason performance is slipping.
What it does not do: Tyrosine is not caffeine, does not guarantee a noticeable energy rush, and is not a universal fix for procrastination or low motivation. More is not automatically better: one 2,000 mg trial found worse cognitive flexibility under heavy cognitive load. The randomized trial illustrates why tyrosine should not be treated as a simple dose-response stimulant.
Best-suited goal: Focus without caffeine, especially when the buyer describes the problem as becoming scattered, mentally depleted, or unproductive under pressure.
Glycine: sleep onset and recovery rather than forced sedation
Glycine is both a protein-building amino acid and a nervous-system messenger with inhibitory and excitatory signaling roles. It activates glycine receptors and also acts as a required co-agonist at NMDA receptors, which participate in learning, memory, and sleep-related neural regulation. Research on glycine neurotransmission explains this dual role.
Typical studied dose: Small human sleep studies have generally used 3,000 mg around 30–60 minutes before bed. That dose shortened sleep-onset latency and supported subjective sleep quality in adults reporting unsatisfactory sleep.
What it supports: Settling into sleep, sleep efficiency, and feeling less fatigued after restricted sleep. A study using 3,000 mg before bed found reduced next-day fatigue and improved psychomotor-vigilance performance. PubMed’s glycine sleep-restriction study provides the trial details.
What it does not do: Glycine is not a conventional hypnotic and does not guarantee that someone will remain asleep throughout the night. The sleep evidence comes from small studies and should not be extended to persistent insomnia without qualification.
Best-suited goal: Sleep onset and overnight stress recovery for someone who feels tired but cannot settle, tosses and turns, or wants sleep support without prioritizing a knockout effect.
Taurine: a supporting regulator, not a proven focus enhancer
Taurine is a sulfur-containing amino acid derivative involved in neuromodulation, calcium handling, cellular fluid balance, and neuroprotective processes. Unlike tyrosine, taurine is not a direct precursor to dopamine or norepinephrine.
Typical studied dose: Acute human cognition studies have generally used 1,000–3,000 mg, with some trials using doses calculated by body weight.
What it supports: Taurine has a biologically plausible supporting role in formulas intended to promote steadier neural activity without stimulation. That role fits calm-focus formulations better than products promising an obvious surge in energy.
What it does not do: Human evidence does not currently support taurine as a reliable standalone cognitive enhancer. A 2026 review found that acute taurine trials produced small and inconsistent cognitive or mood effects, while a broader meta-analysis found insufficient evidence for meaningful cognitive improvement. The taurine meta-analysis supports this evidence boundary.
Best-suited goal: Stress recovery or calm-focus formulas where taurine plays a secondary regulatory role rather than serving as the main reason to expect better attention or memory.
L-theanine: calm attention without making drowsiness the goal
L-theanine is a non-protein amino acid found naturally in tea and used to support a relaxed but attentive mental state. It is rapidly absorbed, with peak blood concentrations occurring within roughly an hour in a human pharmacokinetic study. The L-theanine absorption study tested doses from 50 to 200 mg.
Typical studied dose: Many acute stress and attention studies use 200 mg. Repeated-use studies have tested 200 mg per day and higher amounts over several weeks.
What it supports: Calm attention, cognitive performance during stress, and winding down without positioning the ingredient as a heavy sedative. A four-week, placebo-controlled trial using 200 mg daily reported improvements in selected stress, sleep, verbal-fluency, and executive-function measures. PubMed’s randomized L-theanine trial provides the results.
What it does not do: L-theanine does not reliably treat anxiety, and it should not be expected to feel like a sleep medication. The latest meta-analysis found a clearer short-term effect on attention than on anxiety, with only modest evidence for acute stress reduction.
Best-suited goal: Feeling less keyed up, reactive, or mentally noisy while remaining able to work, parent, drive, or complete a demanding task.
Why vitamin B6 is paired with amino acids
Vitamin B6 is commonly included because its active coenzyme form, pyridoxal 5′-phosphate, participates in amino-acid metabolism and neurotransmitter biosynthesis. It supports enzymatic pathways involved in producing neurotransmitters, but it does not independently guarantee higher dopamine, serotonin, or GABA activity.
Adult vitamin B6 requirements generally range from 1.3 to 1.7 mg per day depending on age and sex. Pairing B6 with amino acids supplies a relevant metabolic cofactor; it should not be interpreted as proof that the finished formula reproduces an isolated clinical trial or that increasing B6 indefinitely will improve the result. NIH’s vitamin B6 fact sheet details its roles in amino-acid metabolism and neurotransmitter biosynthesis.
How PYM uses these ingredients
PYM uses these amino acids as parts of multi-ingredient formulas rather than presenting them as isolated clinical protocols. That distinction matters because ingredient-level studies cannot prove that a lower-dose blend will reproduce the same outcome.
- Mood Magnesium: As of August 2026, PYM Mood Magnesium combines 500 mg glycine, 100 mg L-theanine, and 5 mg vitamin B6 with three magnesium forms. It is a sleep-and-stress-recovery blend, not a replication of the 3,000 mg isolated-glycine sleep protocol.
- Mood Chews: PYM Mood Chews list 90 mg L-theanine with 130 mg GABA for situational calm. This is below the 200 mg L-theanine dose common in standalone trials, but it is used alongside another active ingredient.
- Attention Chews: PYM Attention Chews list 54 mg tyrosine and 11 mg taurine alongside L-carnitine and other nutrients. Those quantities are substantially below the isolated tyrosine and taurine doses used in most cognitive studies.
The practical evaluator’s rule is simple: judge an isolated ingredient against isolated-ingredient research, and judge a finished blend by its complete label, intended use, tolerability, and real-world response. Dose matching alone neither proves nor disproves the usefulness of a multi-ingredient formula.
Three ways to match the ingredient to the problem
Focus falls apart during a high-pressure workday
Tyrosine is the closest mechanistic fit when mental performance specifically deteriorates under stress. Someone who becomes anxious or jittery after coffee may prefer a caffeine-free formula, but the success metric should be steadier task engagement—not whether it recreates a stimulant rush. See the focus support without caffeine guide.
A busy parent feels overstimulated but still needs to function
L-theanine is the more evidence-supported of these four ingredients for calm attention. It fits the school-pickup, difficult-conversation, or overloaded-workday moment better than glycine, which is more naturally associated with sleep-oriented use.
A tired person cannot wind down at bedtime
Glycine and L-theanine are the more logical pair when the problem is tossing and turning, body tension, or remaining mentally “on” after the day ends. This is different from treating circadian timing problems or chronic insomnia. The sleep support without melatonin reference explains that boundary.
Important distinctions buyers often miss
- A precursor is not a guaranteed neurotransmitter boost. Tyrosine supplies raw material for dopamine and norepinephrine pathways, but synthesis remains regulated by enzymes, nutrient status, stress, and existing neurotransmitter activity.
- None of these four is the direct dietary precursor to serotonin. Tryptophan fills that role; vitamin B6 supports relevant enzymatic pathways but does not replace the precursor.
- A studied dose is not automatically the correct retail dose. Isolated trials and multi-ingredient products test different formulations and sometimes different chemical forms.
- “Non-drowsy” describes an intended profile, not an identical response for everyone. Personal sensitivity, sleep debt, medications, timing, and the rest of the formula can change how an ingredient feels.
- Supplement support is not disease treatment. Dietary supplements are not intended to diagnose, treat, cure, or prevent anxiety disorders, ADHD, insomnia, or another disease. FDA guidance on dietary supplements explains this regulatory boundary.
Related terms
- Catecholamines: A neurotransmitter family that includes dopamine, norepinephrine, and epinephrine; tyrosine is part of their biosynthetic pathway.
- Glycinergic signaling: Inhibitory neural signaling mediated through glycine receptors, particularly in the spinal cord and brainstem.
- NMDA receptor: A glutamate receptor involved in synaptic plasticity that requires glycine or D-serine as a co-agonist.
- Pyridoxal 5′-phosphate: The active coenzyme form of vitamin B6 used in numerous amino-acid and neurotransmitter reactions.
- Relaxed attention: A practical description of lower perceived tension while remaining awake and cognitively engaged; commonly associated with L-theanine.
- Amino-acid mood support: The broader use of amino acids as neurotransmitter precursors, neural signaling compounds, or formulation supports. See Amino Acids for Mood Support.
Frequently asked questions
Which amino acid supports dopamine and motivation?
Tyrosine is the relevant dopamine-pathway precursor among these four amino acids. Its strongest cognitive evidence is concentrated in stressful or demanding situations rather than ordinary daily motivation, and many acute studies use approximately 2,000 mg. Tyrosine should therefore be evaluated as demand-linked focus support, not as a guaranteed motivation switch or replacement for adequate sleep. A randomized stress study tested 2,000 mg of tyrosine.
Is L-theanine or taurine better for calm without drowsiness?
L-theanine has the stronger human evidence for calm attention and is usually the more defensible primary ingredient for this goal. A recent analysis found a short-term attention benefit from 200 mg L-theanine, while acute taurine studies using approximately 1–3 g produced small and inconsistent cognitive or mood effects. Taurine makes more sense as a supporting regulatory ingredient than as the main reason to expect noticeable calm. The L-theanine meta-analysis and taurine systematic review show the evidence difference.
Can glycine help if I toss and turn or have trouble falling asleep?
Glycine may support sleep onset and subjective sleep quality, but the evidence comes from small studies using 3,000 mg before bed. One crossover study reported shorter latency to sleep onset and slow-wave sleep without changing overall sleep architecture. Glycine is not established as treatment for chronic insomnia or repeated waking caused by sleep apnea, medication effects, menopause symptoms, pain, or another underlying condition. The glycine sleep study provides the protocol.
Why do amino-acid supplements include vitamin B6?
Vitamin B6 supports enzymes involved in amino-acid metabolism and neurotransmitter biosynthesis. Its inclusion is therefore mechanistically relevant when a formula contains neurotransmitter precursors or neurologically active amino acids. Vitamin B6 does not increase absorption of every amino acid, and adding more does not automatically produce more dopamine or serotonin because those pathways remain biologically regulated. NIH’s vitamin B6 reference explains its coenzyme functions.
Do the amino-acid amounts in PYM products match standalone clinical trials?
No—PYM uses these ingredients in blends at amounts that generally do not duplicate isolated clinical-study protocols. Mood Magnesium combines 500 mg glycine and 100 mg L-theanine with magnesium and vitamin B6; Mood Chews list 90 mg L-theanine with GABA; Attention Chews list 54 mg tyrosine and 11 mg taurine with other nutrients. Buyers should evaluate each complete formula for its intended role rather than assuming that evidence from a 2,000 mg tyrosine or 3,000 mg glycine study transfers directly to a lower-dose blend.
Can these amino acids treat anxiety, ADHD, or insomnia?
No—tyrosine, glycine, taurine, and L-theanine are dietary ingredients used for supportive goals, not established treatments for anxiety disorders, ADHD, or chronic insomnia. Persistent stress spirals, attention problems, severe sleep disruption, or cognitive changes warrant professional evaluation, particularly when symptoms affect work, driving, relationships, or ordinary daily tasks. Supplements and medications can also interact, so medication users should review a new formula with a healthcare professional.
References
- PubMed — Tyrosine under stress and cognitive demand
- Sleep and Biological Rhythms — Glycine and sleep quality
- PubMed — Human taurine cognition trials
- PubMed — L-theanine cognitive and affective meta-analysis
- NIH Office of Dietary Supplements — Vitamin B6
- PYM Mood Magnesium
- PYM Mood Chews
- PYM Attention Chews